Introduction {#section1-1559325820926733}
============

Sepsis is defined as life-threatening organ dysfunction caused by a dysregulated host response to infection.^[@bibr1-1559325820926733]^ The pathogenesis of sepsis is complex and involves multiple aspects such as inflammation, immune response, and coagulation dysfunction.^[@bibr2-1559325820926733][@bibr3-1559325820926733]-[@bibr4-1559325820926733]^ The morbidity and mortality of sepsis remain high,^[@bibr5-1559325820926733]^ which makes the search for therapeutic intervention for sepsis an urgent need for innate immune research. Studies have shown that the most common pathogen of sepsis is Gram-negative bacteria, and the most representative is *Escherichia coli*.^[@bibr6-1559325820926733]^ In early studies, we have established a sepsis model in mice by intraperitoneal injection of lethal dose of *E coli*. In the process of drug screening, it was found that intraperitoneal injection of a lower dose of *E coli* into mice in advance allowed it to obtain resistance to the subsequent lethal dose of *E coli* and survived, and we termed this phenomenon as "inflammatory preconditioning (InP)."^[@bibr7-1559325820926733]^

Interferon regulatory factor (IRF) is an important class of transcription factors which was originally found in the promoter region of the human *interferon β* gene.^[@bibr8-1559325820926733]^ So far, 10 members of the IRF family have been found in vertebrates (IRF10 are eliminated in humans and mice).^[@bibr9-1559325820926733]^ Studies have shown that IRF plays an important role in the regulation of innate and adaptive immune responses.^[@bibr10-1559325820926733]^ Interferon regulatory factor 4, like other members of IRF family, contains a highly conserved N-terminal DNA-binding domain (DBD) and a nonhomologous C-terminal IRF association domain (IAD).^[@bibr11-1559325820926733]^ The expression of IRF4 is restricted to immune cells and is not induced by IFNs.^[@bibr12-1559325820926733]^ As is reported, IRF4 can function as a transcriptional activator or repressor, depending on the ligand with which it interacts.^[@bibr13-1559325820926733]^

Zebrafish (*Danio rerio*), a small tropical fish, has been widely used to study development, homeostasis, and the pathogenesis of human diseases.^[@bibr14-1559325820926733]^ Compared with rodent models, it has many advantages. For example, adult zebrafish can produce a large amount of embryos once mating, which is convenient for drug screening on certain diseases. Coupled with the optical transparency and mature micromanipulation of zebrafish embryo, real-time imaging and dynamic tracing can be realized in vivo in transgenic zebrafish with fluorescent protein labeling,^[@bibr15-1559325820926733]^ which provides great convenience for the study of migration of specific cells or proteins in the disease-related signaling pathways.

Previous studies by our team showed that IRF4 was involved in the immune response to the InP in mice. The expression level of IRF4 was increasing with the prolongation of the preconditioning time. Besides, detection of peripheral blood in mice showed increased levels of anti-inflammatory cytokine interleukin 10 (IL-10), intimating that IRF4/IL-10 anti-inflammatory signaling pathway was activated in InP induced by *E coli*. As a result, it inhibited the further extension of inflammatory response and avoided excessive tissue damage. To deepen our understanding of the activation of inflammatory responses in vivo, animal models need to be established. In the past few decades, zebrafish has gradually become an indispensable model organism in immunological research due to its fast life cycle, transparent embryos, easy genetic manipulation, large sample size, and other advantages.^[@bibr14-1559325820926733],[@bibr15-1559325820926733]^ There are 2 homologues of IRF4 in zebrafish, IRF4a and IRF4b.^[@bibr16-1559325820926733]^ Phylogenetic analysis revealed that *irf4a* has higher homology with mammalian *irf4*. Therefore, we constructed a transgenic zebrafish with systemic overexpression of *irf4a* to identify the role of IRF4a in InP and related immune signaling pathways in zebrafish.

Materials and Methods {#section2-1559325820926733}
=====================

Breeding of Zebrafish {#section3-1559325820926733}
---------------------

Zebrafish is a wild-type (WT) AB line and was purchased from the China Zebrafish Resource Center. The feeding scheme was described in the *Zebrafish Book.* ^[@bibr17-1559325820926733]^ Fertilized eggs were obtained by mating females and males in the early morning. Zebrafish embryos were cultured in the aquaculture water in the temperature-light incubator under a 14/10 light/dark regime at 28.5 °C. Microinjected embryos need to be cultured in E2 water. Pick out dead eggs in time after injection to avoid mold growth. The animal protocol was approved by the Scientific Investigation Board of Science and Technology.

Construction of the Recombinant Plasmid {#section4-1559325820926733}
---------------------------------------

First dissect and collect testis from 5 to 10 adult WT zebrafish in 1.5-mL centrifuge tube, drain the fish water, and add 1 mL TRIzol Reagent (Invitrogen) for the extraction of total RNA according to the manufacturer's instructions. After that, add 8 µL Nuclease-free (NF) water to dissolve the RNA sufficiently and then reverse transcription was performed using the complementary DNA (cDNA) First Strand Synthesis Kit according to the manufacturer's instructions (TransGen). Using the cDNA as template, the *irf4a* coding sequence (CDS) was amplified by polymerase chain reaction (PCR) using gene-specific primers (*irf4a*-F1 and *irf4a*- R1). Then the recovery product of target gene was used as template; add *P2A1* to the coding region of *irf4a* by PCR amplification using primers *irf4a*-V-F and *IRF4a*-*P2A*-R1. The product recovered from the above step was used as template, and the *irf4a* gene with *P2A2* was amplified with primers *irf4a*-V-F and *P2A*-R2 to generate a homology arm for homologous recombination with the vector backbone. Finally, the *Tol2-ef1α-EGFP-SV40* plasmid we constructed earlier was used as a template to amplify the sequence of *EGFP* and the vector backbone linked with *P2A3* by primers Vector-F and Vector-R. The PCR system and reaction procedure were according to the manufacturer's instructions (Takara). The sequences of primers are shown in [Table 1](#table1-1559325820926733){ref-type="table"}.

###### 

Primers Used in PCR.

![](10.1177_1559325820926733-table1)

  Primer         Sequence (5′-3′)
  -------------- ----------------------------------------------------------
  Irf4a-F1       ATGAACTTAGATGGGGACTGC
  Irf4a-R1       GCTCAGTGCAGATGGATGTT
  Irf4a-V-F      CAAAGAATTCCTCGGCCACCATGAACTTAGATGGGGACTGC
  Irf4a-P2A-R1   GAAATTAGTAGCTCCGGATCCCTCTGTCAGGTGTTGTAGACT
  P2A-R2         TCAACATCACCCGCTTGCTTAAGCAAGGAGAAATTAGTAGCTCCGGATC
  Vector-F       AAGCAAGCGGGTGATGTTGAAGAAAATCCTGGTCCTATGGTGAGCAAGGGCGAGGA
  Vector-R       GGTGGCCGAGGAATTCTTTGCCA

Abbreviation: PCR, polymerase chain reaction.

The linearized *Tol2* vector and the fragments of target gene were mixed at a ratio of 1:3 using Minerva Super Fusion Cloning Kit (US Everbright), and the homologous recombination was performed at 50 °C for 20 minutes according to the manufacturer's instructions. Add 10 µL of ligation reaction solution to 100 µL of competent cells, mix gently, and place on ice for 30 minutes. Heat shock at 42 °C for 90 seconds, then quickly put in ice-bath for 2 minutes. Add 200 µL LB liquid medium and shake for 30 minutes at 37 °C with the speed of 200 rpm. The transformation product was then spread on LB solid medium containing ampicillin and incubated at 37 °C overnight.

Sequencing and Screening of Recombinant Plasmids {#section5-1559325820926733}
------------------------------------------------

Three to 5 single colonies were selected from the transformed plates, and add 100 µL LB liquid medium for amplification culture. Sequencing was performed using M13 universal primers (Sangon). The correct recombinant plasmid was screened by sequence alignment and extracted by Endotoxin-free Plasmid Extraction Kit (Tiangen), according to the manufacturer's instructions. Finally, add 50 µL NF water to dissolve the *Tol2-ef1α-irf4a-EGFP* recombinant plasmid. After measuring the concentration, it was diluted to 50 ng/µL for microinjection and stored at −70 °C.

Microinjection of *Tol2-ef1α-irf4a-EGFP* Plasmid {#section6-1559325820926733}
------------------------------------------------

### Transcription of the transposase gene in vitro {#section7-1559325820926733}

The *pCS-TP* plasmid (a generous gift from Xinjia) was linearized with XbaI restriction enzyme, and transcription was performed by the mMESSAGE mMACHINE SP6 Transcription Kit (Ambion), according to the manufacturer's instructions. Then the product was purified by lithium chloride precipitation method. And finally the transposase messenger RNA (mRNA) was resuspended in 20 µL NF water. Determine the RNA concentration and diluted to 50 ng/µL for microinjection. Store frozen at −70 °C.

### Solution preparation {#section8-1559325820926733}

For the experimental group, mix the transposase mRNA with *Tol2-ef1α-irf4a-EGFP* recombinant plasmid in equal proportions (with the final concentration of both were 25 ng/μL); for the positive control group, mix the transposase mRNA with *Tol2-ef1α-EGFP* plasmid (same concentration as above); for the negative control group, mix the transposase mRNA with the *irf4a* gene fragment (same concentration as above). About 200 eggs were injected, and the injection volume of each fertilized egg was about 1 nL.

### Microinjection {#section9-1559325820926733}

Pull a 1.0-mm-diameter glass capillary into a needle shape with a needle puller (NALISHIGE PN-31) and draw 1 µL solution with a microloading tip (Eppendorf). Then the injection needle is inserted into the needle holder (Märzhäuser Wetzlar FP-MM) for fixation. Use a toothless forceps to break the needle tip into an inclined plane under the stereomicroscope (Olympus SZ51) with the magnification of 3.2 and adjust the volume of droplet to 1 nL. The baffle was taken out and fertilized eggs were collected every 10 minutes after broodstock spawning and arranged in an injection mold. When the cell morphology became regular under the microscope, an injection needle was inserted from the embryonic animal pole into the cytoplasm for injection (ASI MPPI-3).^[@bibr18-1559325820926733]^

Microscopy and Screening of irf4a Transgenic Zebrafish {#section10-1559325820926733}
------------------------------------------------------

The injected embryos were transferred to a petri dish containing E2 water and cultured in a constant temperature incubator at 28.5 °C. The expression of fluorescence was observed at days 2 to 3 post fertilization. Select F0 generations that express EGFP in multiple tissues of the body and maintain them to sexual maturity. F0 was then mated with AB line zebrafish to produce F1 offspring. If F1 larvae can express green fluorescence normally as the parent fish, then F0 can be used as a founder. Furthermore, *irf4a* should be amplified by PCR to identify whether it is integrated into the F1 zebrafish genome, and finally, we can obtain stably expressed Tg (*ef1α*: *irf4a*, *EGFP*) zebrafish. Microscopy of *irf4a* transgenic zebrafish larvae was performed using the fluorescence microscope (Olympus V1.18). Images were processed using the Olympus Capture software.

Results {#section11-1559325820926733}
=======

Sequence Characterization and Structure Analysis of Zebrafish irf4a {#section12-1559325820926733}
-------------------------------------------------------------------

The CDS of *Danio rerio irf4a* (accession no. NM_001122710.1) consists of 1383 nucleotides which encodes 460 amino acids (AAs). Sequence analysis showed 2 conserved domains of protein IRF4a, called IRF (17aa-122aa) and IRF-3 (247aa-428aa), as shown in [Figure 1B](#fig1-1559325820926733){ref-type="fig"}. These 2 domains correspond to the DBD and IAD domains of the IRF family, respectively. We can know from the tertiary structure of the 2 conserved domains predicted by the SWISS-MODEL website that both of them contain the basic forms constituting the secondary structure of protein, such as α-helix, β-sheet, and β-turn. The difference is that the IRF-3 domain contains more α helices, and the adjacent α helices are connected by regular β-turn, which is supposed to be more stable, while IRF domain consists of more β turns, which is presumed to be more flexible and easier to bind with other proteins and factors. Studies have shown that each member of IRF family contains a conserved N-terminal region of about 120 AAs, which folds into a structure that binds specifically to the interferon consensus sequence.^[@bibr19-1559325820926733]^ That is consistent with our speculation.

![Sequence characterization and structure analysis of *irf4a*. A, Conserved domain of zebrafish IRF4a. IRF4a consists of 2 conserved domains, called IRF and IRF-3. And the tertiary structure of these 2 domains was predicted through the SWISS-MODEL website. B, Secondary structure of IRF4a predicted by Protean. The blue stripes in the figure represent hydrophilicity, positive values represent hydrophilic regions, otherwise, hydrophobic regions. The pink stripes represent the antigen index, and the positive ones may form antigen determinants, while the negative ones may not. The yellow stripes represent surface probability plot, positive values indicate that these regions may be located on the surface of protein IRF4a, and vice versa. The meaning of other symbols is shown in the legend. IRF indicates interferon regulatory factor.](10.1177_1559325820926733-fig1){#fig1-1559325820926733}

Then we predicted the secondary structure of IRF4a using Protean software^[@bibr20-1559325820926733]^ ([Figure 1C](#fig1-1559325820926733){ref-type="fig"}), in which α-helices and β-sheets are evenly distributed, while β-turns and random coils are permutated in dense fragments at the site of 140 to 220 AAs. Kyte-Doolittle analysis showed that IRF4a had high hydrophilicity and few hydrophobic regions. Notably, most of the regions with high antigen index coincide with the hydrophilic regions, indicating that segments forming the epitope are more hydrophilic. Furthermore, the surface probability plot predicted by the Emini method are mainly distributed at the site of 40 to 60, 160 to 170, 280 to 290, 300 to 310, 350 to 360, and 400 to 410 AAs, indicating that the AA residues in these regions are likely to be located on the surface of protein IRF4a.

The Schematic Diagram of Constructing irf4a Transgenic Zebrafish {#section13-1559325820926733}
----------------------------------------------------------------

The *Tol2-ef1α-EGFP-SV40* plasmid was used as the vector backbone and should be linearized. As shown in [Figure 2](#fig2-1559325820926733){ref-type="fig"}, the same sequence as both ends of *irf4a* was generated on the linearized *Tol2* vector by PCR amplification. As well, the target gene should produce a sequence homologous to the ef1α promoter at the 5′-end and a "self-cleaving" 2A peptide (P2A)^[@bibr21-1559325820926733]^ at the 3′-end, and the P2A is correspondingly amplified on the vector. Then the linearized *Tol2* plasmid was mixed with *irf4a* for homologous recombination. The recombinant products were directly transformed into *DH5α* competent cells and spread on the LB medium with ampicillin for overnight culture. After that, select several single colonies for sequencing and those without mutations should be reactivated to extract the endotoxin-free *irf4a* recombinant plasmid.

![Experimental principles and procedures. Construction of *irf4a* transgenic zebrafish includes 6 steps. First off, amplify the CDS of irf4a and the sequence of "self-cleaving" 2A peptide. Then obtain the linearized *Tol2* expression vector with *EGFP* by PCR. Thirdly, the fragments of *irf4a*, *P2A*, and *Tol2* vector were ligated using one-step cloning kit. Fourthly, resistance screening and sequencing of *irf4a* recombinant plasmid. Fifthly, microinjection of *Tol2-ef1α-irf4a-EGFP* plasmid. Finally, through fluorescence screening, we can obtain *EGFP*-labeled *irf4a* transgenic zebrafish driven by *ef1α* promoter. CDS indicates coding sequence; PCR, polymerase chain reaction.](10.1177_1559325820926733-fig2){#fig2-1559325820926733}

To increase the efficiency of generating stable *irf4a*-expressing lines, the *Tol2-ef1α-irf4a-EGFP* plasmid and *Tol2* transposase mRNA were coinjected into zebrafish embryos at one-cell stage. Subsequently, the juveniles expressing green fluorescence was selected and raised to sexual maturity (F0 generation). For further screening the founder fish,^[@bibr22-1559325820926733]^ F0 was mated with WT zebrafish to produce F1 offspring, and the possibility of F0 as a founder was based on the efficiency of *EGFP* expression in F1 embryos. The zebrafish genome of F1 generation with green fluorescence was used as a template to amplify *irf4a* partial sequence and sequencing to identify whether target gene was integrated into genome (data not shown). In this way, we can eventually acquire the stably inherited F1 of *irf4a* transgenic zebrafish.

Cloning of irf4a and Linearization of Tol2 Vector {#section14-1559325820926733}
-------------------------------------------------

We employed nested PCR to amplify *irf4a* and ligated *P2A* to the 3′-end of the CDS of target gene by overlapping PCR. As shown in [Figure 3A](#fig3-1559325820926733){ref-type="fig"}, the full length of *irf4a* coding region is 1383 bp, but the length of the fragment we actually amplified is 1415 bp, which is because the reverse primer (*irf4a*-R1) binds to the downstream of the CDS. There was no interest band in lanes 1 and 2, indicating that the specificity of these 2 primer pairs was not high. Next we used the recovery product as template and linked the vector homology arm and *P2A1* to both ends of *irf4a*. In [Figure 3B](#fig3-1559325820926733){ref-type="fig"}, the band size and brightness of lanes 1, 2, and 3 are similar, indicating that the amplification efficiency of Pfu and Taq DNA polymerases is equivalent when the template is relatively pure. Subsequently, the *P2A2* was also ligated to *irf4a*. As shown in [Figure 3C](#fig3-1559325820926733){ref-type="fig"}, the size of the target band was 1450 bp. And the differences in brightness suggested that high-fidelity Pfu DNA polymerase seems to be more dependent on template concentrations in PCR systems compared with Taq DNA polymerase.^[@bibr23-1559325820926733]^

![Amplification of *irf4a* with homologous arm and vector linearization. A, Obtaining *irf4a* from WT zebrafish cDNA. Groups 1, 2, and 3 represent 3 different primers, respectively. B, Add *P2A1* and homologous arm of vector to both ends of *irf4a*. Group 1 was amplified by Pfu DNA polymerase. Groups 2 and 3 were amplified by Taq DNA polymerase, which shared the same PCR system. C, *P2A2* was linked to the target gene by overlapping PCR. Groups 1 and 2 was amplified by Pfu DNA polymerase, while groups 3 and 4 were amplified by Taq DNA polymerase. The concentration of template in groups 1 and 3 was 10 ng/μL, while that in groups 2 and 4 was 68 ng/μL. As control, "*irf4a*" and "*P2A1*" were the recovery products of the bands in Figure 3A and 3B, respectively. D, *P2A3* was ligated to the *Tol2* vector. The 2 groups shared the same PCR system. cDNA indicates complementary DNA; PCR, polymerase chain reaction; WT, wild type.](10.1177_1559325820926733-fig3){#fig3-1559325820926733}

Additionally, we use the *Tol2-ef1α-EGFP-SV40* plasmid as template to produce the same sequence as both ends of the target gene by PCR for homologous recombination. As shown in [Figure 2D](#fig2-1559325820926733){ref-type="fig"}, *P2A3*, which overlaps 20 base pairs with *P2A2*, was ligated to the *Tol2* vector. And the length of the linearized vector with homology arms is 5.5 kb. By the way, the electrophoretic band is affected by the amount of sample loaded, the concentration of agarose gel, and the voltage. For example, there is a deviation in the band width and the swimming rate among each group shown in [Figure 3C](#fig3-1559325820926733){ref-type="fig"}, which may be due to the unstable voltage. As a result, it leads the sample to form a groove in electrophoresis, resulting in visual deviation.

Homologous Recombination and Identification of Tol2-ef1α-irf4a-EGFP Plasmid {#section15-1559325820926733}
---------------------------------------------------------------------------

The linearized *Tol2* plasmid was homologously recombined with *irf4a* and transformed into competent cells. Then we selected 1 to 5 single colonies for expanded culture and plasmid extraction. As shown in [Figure 4A](#fig4-1559325820926733){ref-type="fig"}, the molecular weight of group T2 was larger than that of the original *Tol2* plasmid, and it's most likely a recombinant plasmid. Sequencing alignment revealed no mutation in the coding genes. Therefore, T2 was the correct *Tol2-ef1α-irf4a-EGFP* recombinant plasmid. [Figure 4B](#fig4-1559325820926733){ref-type="fig"} depicts the map of the recombinant plasmid. 5′-Tol2 and 3′-Tol2 can transpose in the presence of transposase and integrate the internal genes into the host genome without causing any rearrangement and modification at the target site. P2A mediated the "cleavage" between 2 adjacent proteins, enabling *irf4a* and *EGFP* to be expressed separately. SV40 poly (A) was used as a termination signal to terminate the transcription of *EGFP*, and it can enhance the stability of mRNA and improve translation efficiency. It should be noted that *irf4a* and the EGFP-encoding gene are ligated in series with no termination, and both of them are driven by the ef1α promoter.

![Construction of recombinant plasmids. A, Electrophoresis detection of recombinant plasmid. Groups T1 to P3 are plasmids extracting from 6 different individual colonies, and the *Tol2-ef1α-EGFP-SV40* plasmid was used as a negative control. B, The map of recombinant plasmid. The recombinant plasmid is composed of *Tol2* vector backbone, *ef1α* promoter, *irf4a, P2A*, *EGFP* encoding gene, and *SV40* poly (A).](10.1177_1559325820926733-fig4){#fig4-1559325820926733}

Fluorescent Screening of irf4a Transgenic Zebrafish {#section16-1559325820926733}
---------------------------------------------------

The *Tol2-ef1α-irf4a-EGFP* recombinant plasmid was extracted without endotoxin and mixed with transposase mRNA for microinjection. Among the embryos injected with *irf4a* recombinant plasmid, about one quarter expressed green fluorescence. And most of them were expressed in spine, tail, eyes, heart, and brain ([Figure 5A](#fig5-1559325820926733){ref-type="fig"}). As a ubiquitous promoter, *ef1α* (elongation factor-1 alpha) was reported to promote the expression of the downstream genes in the lens, retina, brain, heart, gill, and other tissues of zebrafish,^[@bibr24-1559325820926733]^ which is consistent with our results. As a selection marker, EGFP could be expressed normally, indicating that the upstream target gene, *irf4a*, should have been expressed successfully. In addition, larvae injected with the *Tol2-ef1α-EGFP* plasmid as positive control were observed to express green fluorescence in multiple tissues throughout the body ([Figure 5B](#fig5-1559325820926733){ref-type="fig"}), while negative control juveniles did not express green fluorescence ([Figure 5C](#fig5-1559325820926733){ref-type="fig"}).

![Fluorescent screening of transgenic zebrafish. A, Image of *irf4a* transgenic juvenile zebrafish at 3 dpf. B, Image of EGFP-expressing juvenile zebrafish at 3 dpf (as positive control). C, Image of juvenile zebrafish microinjected with the fragment of *irf4a* at 3 dpf (as negative control). To ensure the accuracy of the results, we photographed the juveniles of zebrafish under optical microscope and fluorescence microscope, respectively. dpf indicates days post fertilization.](10.1177_1559325820926733-fig5){#fig5-1559325820926733}

Discussion {#section17-1559325820926733}
==========

Over the past 2 decades, many studies have focused on the role of IRF4 in the regulation of immune responses, immune cell activation, and immune cell differentiation.^[@bibr25-1559325820926733][@bibr26-1559325820926733]-[@bibr27-1559325820926733]^ A recent study reported that graded expression of IRF4 developmentally coordinates isotype switching with plasma cell differentiation.^[@bibr28-1559325820926733]^ Besides, Tr1 (type 1 regulatory T) cell development and suppressive function of Itk (IL-2 inducible T-cell kinase)-deficient cells can be restored by the expression of the transcription factor IRF4.^[@bibr29-1559325820926733]^ The other study use the loss-of-function, RNA interference--based genetic screen to prove that IRF4 inhibition is toxic to myeloma cell lines.^[@bibr30-1559325820926733]^ Reducing IRF4 expression is reported to restore the functional and metabolic properties of antigen-specific T cells and promoted memory-like T-cell development.^[@bibr31-1559325820926733]^

Furthermore, the members of IRF family are closely related to the polarization and typing of macrophages.^[@bibr32-1559325820926733]^ And IRF5 and IRF4 play important roles in driving the polarization of nonpolarized macrophages (M0 phenotype) to classical activated macrophages (M1 phenotype) and alternative activated macrophages (M2 phenotype), respectively.^[@bibr33-1559325820926733]^ Interferon regulatory factor 5 is required for the expression of IL-6, tumor necrosis factor α, IL-12, and other pro-inflammatory cytokines in Toll-like receptor-mediated macrophages, leading to the formation of M1 phenotype in macrophages.^[@bibr34-1559325820926733]^ In contrast, IRF4 stimulates the secretion of anti-inflammatory cytokines such as IL-10 and is a key transcriptional factor that controls the initiation and polarization of M2 macrophages.^[@bibr35-1559325820926733]^ As we know, the balance of M1/M2 is controlled by activity of intracellular signaling mediators activated by exogenous stimuli, which is important to maintain the stability of the internal environment. Although IRF4 was sufficiently studied in mammals, there were few researches on the function of zebrafish IRF4 and its regulation mechanism.

In earlier study, we found that IRF4 played an important role in monophosphoryl lipid A (MPLA)-induced InP in mice.^[@bibr7-1559325820926733]^ In this study, we constructed the transgenic zebrafish with overexpression of IRF4a, for one thing, to determine whether IRF4a could play the same role with mammal IRF4; whether the overexpression of *irf4a* can improve the survival rate of sepsis in zebrafish induced by lethal dose of *E coli*; and whether irf4a also plays an anti-inflammatory role in InP in zebrafish by activating the anti-inflammatory cytokines such as IL-10. For another, to investigate the effects of increased expression of IRF4a in zebrafish on the polarization of macrophages as a complement to macrophage typing.

What's more, we also encountered some problems during the process of constructing *Tol2-ef1α-irf4a-EGFP* recombinant plasmid. For example, we found it was difficult to acquire *irf4a* using cDNA of embryos or juvenile zebrafish as template. By contrast, *irf5* was more easily obtained under the same conditions. Therefore, we speculated whether this was related to the underdeveloped immune system and low expression of *irf4a* in juveniles. It was reported that the expression level of *irf4a* in zebrafish was highest in the testis and moderately high in liver, spleen, trunk kidney, muscle, heart, and intestine.^[@bibr36-1559325820926733]^ In terms of this, we dissected and collected testis from 5 to 10 adult zebrafish to amplify the *irf4a* target gene. Another problem we solved is the independent expression of *irf4a* and *EGFP*. As is mentioned earlier, *P2A* is a self-cleaving sequence that mediates "cleavage" between 2 proteins and is widely used in eukaryotic expression systems.^[@bibr21-1559325820926733]^ Thereby, we added a *P2A* sequence between *irf4a* and *EGFP*-encoding gene, which largely avoided low protein production and low levels of downstream gene expression when the 2 genes were expressed in fusion.

Conclusion {#section18-1559325820926733}
==========

In conclusion, we constructed a transgenic zebrafish with high expression of *irf4a* throughout the whole body based on the *Tol2* transgenic system, providing a model basis for studying the role of IRF4a in MPLA-induced InP. Subsequent research will be carried out on the identification of target gene and expression levels of mRNA and protein. In addition, it serves as a powerful tool to study the role of IRF4a in the immune response and its effect on macrophage polarization as well. As we all know, transgenic and knockout animals are very effective tools for studying gene functions. In future research, we will proceed to build the *irf4a* knockout zebrafish to characterize the gene function more comprehensively.
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